The use of high-dose ifosfamide in the combined treatment of soft tissue sarcomas (first experience in the national center of oncology and hematology in bishkek)

A. A. Babalaev; Бабалаев А. А.; A. T. Alymkulov; Алымкулов А. Т.; T. A. Abdyldaev; Абдылдаев Т. А.; R. T. Reshetin; Решетин Р. В.; U. A. Turgunbaev; Тургунбаев У. А.; D. K. Aydaralyeva; Айдаралиева Д. К.

The use of high-dose ifosfamide in the combined treatment of soft tissue sarcomas (first experience in the national center of oncology and hematology in bishkek)

Authors: Babalaev A.A.¹, Alymkulov A.T.¹, Abdyldaev T.A.¹, Reshetin R.T.¹, Turgunbaev U.A.¹, Aydaralyeva D.K.¹
Affiliations:
1. National Center of Oncology and Hematology
Issue: Vol 9, No 4 (2017)
Pages: 34-37
Section: SOFT TISSUE SARCOMAS
Published: 15.12.2017
URL: https://sarbon.abvpress.ru/jour/article/view/307
ID: 307

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

In our article the experience of treating patients with soft tissue sarcomas in the National Center of Oncology and Hematology is given. The purpose of the study was the use of modern methods of diagnosis and treatment of soft tissue sarcomas. For the first time in the Kyrgyz Republic, modern schemes of drug therapy were applied at the stage of combined treatment with the use of high-dose polychemotherapy regimens in the form of continuous 24-hour infusion. As a result of our study of patients with soft tissue sarcomas, mortality at the follow-up period from 8 to 35 months. was 46,2%, which corresponds to the average statistical data.